BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nahon P, Sutton A, Rufat P, Simon C, Trinchet JC, Gattegno L, Beaugrand M, Charnaux N. Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis. World J Gastroenterol 2008; 14(5): 713-719 [PMID: 18205260 DOI: 10.3748/wjg.14.713]
URL: https://www.wjgnet.com/1948-5182/full/v14/i5/713.htm
Number Citing Articles
1
Hossein Khorramdelazad, Elham Hakimizadeh, Gholamhossein Hassanshahi, Mohammadtaghi Rezayati, Hossein Sendi, Mohammad Kazemi Arababadi. CCR5 Δ 32 mutation is not prevalent in Iranians with chronic HBV infectionJournal of Medical Virology 2013; 85(6): 964 doi: 10.1002/jmv.23510
2
Khadija Rebbani, Sayeh Ezzikouri, Agnès Marchio, Mostafa Ababou, Bouchra Kitab, Anne Dejean, Mostafa Kandil, Pascal Pineau, Soumaya Benjelloun. Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan populationInfection, Genetics and Evolution 2014; 26: 1 doi: 10.1016/j.meegid.2014.04.019
3
Trina J Stewart, Mark J Smyth. Chemokine–chemokine receptors in cancer immunotherapyImmunotherapy 2009; 1(1): 109 doi: 10.2217/1750743X.1.1.109
4
Alicja E. Grzegorzewska, Adrianna Mostowska. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_8-1
5
Erinaldo Ubirajara Damasceno dos Santos, Géssica Dayane Cordeiro de Lima, Micheline de Lucena Oliveira, Sandra de Andrade Heráclio, Hildson Dornelas Angelo da Silva, Sergio Crovella, Maria de Mascena Diniz Maia, Paulo Roberto Eleutério de Souza/. CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control studyMemórias do Instituto Oswaldo Cruz 2016; 111(3): 174 doi: 10.1590/0074-02760150367
6
Dennis A. Smith, Anthony Harrison, Paul Morgan. Multiple Factors Govern the Association between Pharmacology and Toxicity in a Class of Drugs: Toward a Unification of Class Effect TerminologyChemical Research in Toxicology 2011; 24(4): 463 doi: 10.1021/tx100408v
7
Hongxia Ma, Yongqian Shu, Shiyang Pan, Jiaping Chen, Juncheng Dai, Guangfu Jin, Zhibin Hu, Hongbing Shen. Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in ChineseLung Cancer 2011; 74(2): 164 doi: 10.1016/j.lungcan.2011.03.005
8
Mohammad Kazemi Arababadi, Ali Akbar Pourfathollah, Abdollah Jafarzadeh, Gholamhossein Hassanshahi, Maryam Mohit, Masomeh Hajghani, Behzad Nasiri Ahmadabadi, Derek Kennedy. Evaluation of CCR5 Expression on NK Cells in Iranian Patients With Occult Hepatitis B InfectionLaboratory Medicine 2010; 41(12): 735 doi: 10.1309/LMAUISL84Q4SRSBT
9
Ting Liu, Jin-Xia Zhai, Han-Yong Wang, Xing-Hua Wang, Li-Wei Zou, Wen-jing Fan, Dong-Qing Ye. Meta-analysis of MCP-1 promoter −2518 A/G polymorphism and SLE susceptibilityMolecular Biology Reports 2012; 39(8): 8475 doi: 10.1007/s11033-012-1701-1
10
Maylis Dagouassat, Nadine Suffee, Hanna Hlawaty, Oualid Haddad, Faten Charni, Christelle Laguillier, Roger Vassy, Lo��c Martin, Pierre-Olivier Schischmanoff, Liliane Gattegno, Olivier Oudar, Angela Sutton, Nathalie Charnaux. Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cellsInternational Journal of Cancer 2009; : NA doi: 10.1002/ijc.24800
11
Khodayar Ghorban, Maryam Dadmanesh, Gholamhossein Hassanshahi, Mohammad Momeni, Mohammad Zare-Bidaki, Mohammad Kazemi Arababadi, Derek Kennedy. Is the CCR5 Δ 32 Mutation Associated with Immune System-Related Diseases?Inflammation 2013; 36(3): 633 doi: 10.1007/s10753-012-9585-8
12
Mohammad Kazemi Arababadi, Ali Akbar Pourfathollah, Abdollah Jafarzadeh, Gholamhossein Hassanshahi, Maryam Mohit, Masomeh Hajghani, Ali Shamsizadeh. Peripheral Blood CD8+T Cells CCR5 Expression and Its Δ32 Mutation in Iranian Patients with Occult Hepatitis B InfectionsLaboratory Medicine 2010; 41(4): 226 doi: 10.1309/LMVUKWROX0EBQR01
13
Alicja E. Grzegorzewska, Monika K. Świderska, Adrianna Mostowska, Paweł P. Jagodziński. Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis PatientsBioMed Research International 2017; 2017: 1 doi: 10.1155/2017/3713025
14
N. G. Danilenko, M. G. Siniauskaya, S. P. Lukashyk, I. A. Karpov, O. G. Davydenko. “Double Punch”: Hepatitis C in Patients with Genetic Defects of Iron MetabolismCytology and Genetics 2019; 53(5): 407 doi: 10.3103/S0095452719050062
15
Yan Wang, Xiao-Ai Zhang, Xiao Yang, Zhi-Hao Wu, Zhi-Chun Feng. A MCP-1 promoter polymorphism at G-2518A is associated with spontaneous preterm birthMolecular Genetics and Genomics 2015; 290(1): 289 doi: 10.1007/s00438-014-0921-6
16
Alicja E. Grzegorzewska, Adrianna Mostowska. Biomarkers in Liver DiseaseBiomarkers in Disease: Methods, Discoveries and Applications 2017; : 927 doi: 10.1007/978-94-007-7675-3_8
17
EMMANOUIL LIARMAKOPOULOS, GEORGE THEODOROPOULOS, ANNA VAIOPOULOU, SPYROS RIZOS, GERASIMOS ARAVANTINOS, GREGORY KOURAKLIS, NIKOLAOS NIKITEAS, MARIA GAZOULI. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer riskMolecular Medicine Reports 2013; 7(3): 887 doi: 10.3892/mmr.2012.1247
18
Meenakshi Sachdeva, Yogesh K Chawla, Sunil K Arora. Immunology of hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(17): 2080-2090 doi: 10.4254/wjh.v7.i17.2080
19
Sulemon Chaudhry, Jean Emond, Adam Griesemer. Immune Cell Trafficking to the LiverTransplantation 2019; 103(7): 1323 doi: 10.1097/TP.0000000000002690
20
Chun-Min Liang, Long Chen, Heng Hu, Hui-Ying Ma, Ling-Ling Gao, Jie Qin, Cui-Ping Zhong. Chemokines and their receptors play important roles in the development of hepatocellular carcinomaWorld Journal of Hepatology 2015; 7(10): 1390-1402 doi: 10.4254/wjh.v7.i10.1390
21
M Sadeghi, I Lahdou, H Oweira, V Daniel, P Terness, J Schmidt, K-H Weiss, T Longerich, P Schemmer, G Opelz, A Mehrabi. Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinomaBritish Journal of Cancer 2015; 113(5): 756 doi: 10.1038/bjc.2015.227
22
Łukasz Kruszyna, Margarita Lianeri, Błażej Rubis, Hanna Knuła, Maria Rybczyńska, Sylwia Grodecka-Gazdecka, Paweł P. Jagodziński. CCL2 −2518 A/G single nucleotide polymorphism as a risk factor for breast cancerMolecular Biology Reports 2011; 38(2): 1263 doi: 10.1007/s11033-010-0225-9
23
Hossein Khorramdelazad, Yousef Mortazavi, Mohammad Momeni, Mohammad Kazemi Arababadi, Behjat Kalantary Khandany, Mozhgan Moogooei, Gholamhossein Hassanshahi. Lack of Correlation Between the CCR5-Δ32 Mutation and Acute Myeloid Leukemia in Iranian PatientsIndian Journal of Hematology and Blood Transfusion 2015; 31(1): 29 doi: 10.1007/s12288-014-0408-y
24
Canan Kucukgergin, Ferruh K. Isman, Bedia Cakmakoglu, Oner Sanli, Sule Seckin. Association of Polymorphisms inMCP-1, CCR2,andCCR5Genes with the Risk and Clinicopathological Characteristics of Prostate CancerDNA and Cell Biology 2012; 31(8): 1418 doi: 10.1089/dna.2012.1716
25
Xing-Zhizi Wang, Xiao-Ying Huang, Jin-Guang Yao, Chao Wang, Qiang Xia, Xi-Dai Long. Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1Oncotarget 2018; 9(44): 27321 doi: 10.18632/oncotarget.24535
26
Chao-Bin Yeh, Hsiu-Ting Tsai, Yi-Chen Chen, Wu-Hsien Kuo, Tzy-Yen Chen, Yi-Hsien Hsieh, Ming-Chih Chou, Shun-Fa Yang. Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinomaJournal of Surgical Oncology 2010; 102(3): 264 doi: 10.1002/jso.21623
27
Pierre Nahon, Jessica Zucman-Rossi. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosisJournal of Hepatology 2012; 57(3): 663 doi: 10.1016/j.jhep.2012.02.035
28
Asmaa M. Zahran, Helal F. Hetta, Amal Rayan, Abeer Sharaf Eldin, Elham Ahmed Hassan, Hussein Fakhry, Ahmed Soliman, Omnia El-Badawy. Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomesCancer Immunology, Immunotherapy 2020; 69(7): 1253 doi: 10.1007/s00262-019-02465-y
29
Vasudha Sambyal, Kamlesh Guleria, Ruhi Kapahi, Mridu Manjari, Meena Sudan, Manjit Singh Uppal, Neeti Rajan Singh. Association of the -2518 A/G Polymorphism of MCP-1 with Breast Cancer in Punjab, North-West IndiaAsian Pacific Journal of Cancer Prevention 2015; 16(16): 7243 doi: 10.7314/APJCP.2015.16.16.7243
30
Santosh K. Singh, Manoj K. Mishra, Brian M. Rivers, Jennifer B. Gordetsky, Sejong Bae, Rajesh Singh. Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular CarcinomaCancers 2020; 12(4): 883 doi: 10.3390/cancers12040883
31
Chi-Chung Chang, Shu-Chen Chen, Yi-Hsien Hsieh, Yi-Chen Chen, Tzy-Yen Chen, Yin-Hung Chu, Hui-Jen Ma, Ming-Chih Chou, Hsiu-Ting Tsai, Shun-Fa Yang. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinomaClinical Chemistry and Laboratory Medicine 2009; 47(4) doi: 10.1515/CCLM.2009.092